iTeos Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2018 - 2019
Revenue	35	35	12.6	267.63	344.78	-	Upgrade
Revenue Growth (YoY)	-	177.89%	-95.29%	-22.38%	-	-	Upgrade
Gross Profit	35	35	12.6	267.63	344.78	-	Upgrade
Selling, General & Admin	47.36	49.08	50.4	43.95	40.51	15.34	Upgrade
Research & Development	137.55	142.73	109.77	96.19	59.37	29.61	Upgrade
Operating Expenses	184.91	191.81	160.17	140.13	99.87	44.95	Upgrade
Operating Income	-149.91	-156.81	-147.57	127.5	244.9	-44.95	Upgrade
Interest & Investment Income	30.44	30.87	31.77	11.36	0.08	-	Upgrade
Other Non Operating Income (Expenses)	1.62	5.6	6.77	9.88	11.49	6.86	Upgrade
Pretax Income	-117.85	-120.34	-109.03	148.74	256.46	-38.09	Upgrade
Income Tax Expense	12.96	14.07	3.61	52.08	41.94	-0.06	Upgrade
Net Income	-130.81	-134.41	-112.64	96.65	214.52	-38.03	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	-	-	5.37	Upgrade
Net Income to Common	-130.81	-134.41	-112.64	96.65	214.52	-43.4	Upgrade
Net Income Growth	-	-	-	-54.95%	-	-	Upgrade
Shares Outstanding (Basic)	42	40	36	36	35	15	Upgrade
Shares Outstanding (Diluted)	42	40	36	38	38	15	Upgrade
Shares Change (YoY)	18.24%	13.17%	-5.30%	-0.02%	150.49%	7336.28%	Upgrade
EPS (Basic)	-3.09	-3.32	-3.15	2.72	6.10	-2.88	Upgrade
EPS (Diluted)	-3.09	-3.32	-3.15	2.56	5.68	-2.88	Upgrade
EPS Growth	-	-	-	-54.93%	-	-	Upgrade
Free Cash Flow	-100.33	-99.81	-106.72	-112.13	511.96	-25.53	Upgrade
Free Cash Flow Per Share	-2.37	-2.47	-2.98	-2.97	13.55	-1.69	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	-	Upgrade
Operating Margin	-428.31%	-448.03%	-1171.69%	47.64%	71.03%	-	Upgrade
Profit Margin	-373.75%	-384.04%	-894.34%	36.11%	62.22%	-	Upgrade
Free Cash Flow Margin	-286.67%	-285.18%	-847.34%	-41.90%	148.49%	-	Upgrade
EBITDA	-148.65	-155.57	-146.68	128.3	245.5	-44.42	Upgrade
EBITDA Margin	-	-	-	47.94%	71.21%	-	Upgrade
D&A For EBITDA	1.26	1.24	0.9	0.8	0.6	0.54	Upgrade
EBIT	-149.91	-156.81	-147.57	127.5	244.9	-44.95	Upgrade
EBIT Margin	-	-	-	47.64%	71.03%	-	Upgrade
Effective Tax Rate	-	-	-	35.02%	16.35%	-	Upgrade
Revenue as Reported	35	35	12.6	267.63	344.78	-	Upgrade

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q